Efficacy and Safety Assessment of Beltavac® With Polymerized Extract of HDM

PHASE3RecruitingINTERVENTIONAL
Enrollment

350

Participants

Timeline

Start Date

January 17, 2022

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions
House Dust Mite Allergy
Interventions
BIOLOGICAL

House dust mites allergoid from Dermatophagoides pteronyssinus and Dermatophagoides farinae

The vaccine will be administered according to a rush schedule meaning one administration each month for 1 year

BIOLOGICAL

Placebo

The vaccine will be administered according to a rush schedule meaning one administration each month for 1 year

Trial Locations (18)

Unknown

RECRUITING

Hospital Vega Baja, Orihuela

RECRUITING

Hospital General de Granollers, Granollers

WITHDRAWN

Hospital de Canarias, Santa Cruz de Tenerife

RECRUITING

Hospital de la Plana, Castellon

RECRUITING

Hospital Regional de Málaga, Málaga

RECRUITING

Complejo Hospitalario de Navarra, Pamplona

RECRUITING

Fundacion Sanitaria Sant Pere Claver, Barcelona

RECRUITING

Hospital de Bellvitge, Barcelona

RECRUITING

Hospital Germans Trias i Pujol, Barcelona

RECRUITING

Hospital infantil Vall d Hebron, Barcelona

RECRUITING

Hospital Val d ' Hebron, Barcelona

RECRUITING

Hospital General de Castellón, Castelló

WITHDRAWN

Hospital Virgen de la Arrixaca, Murcia

RECRUITING

Hospital de Fatima, Seville

RECRUITING

Hospital Virgen Macarena, Seville

RECRUITING

Hospital Clinico Universitario de Valencia, Valencia

RECRUITING

Hospital Politecnico de la Fé, Valencia

RECRUITING

Hospital Universitario Infantil de la Fé, Valencia

All Listed Sponsors
lead

Probelte Pharma S.L.U.

INDUSTRY